Author:
Dharmarajan Sai,Jung Tae Hyun
Publisher
Springer International Publishing
Reference57 articles.
1. FDA. Clinical Trial Imaging Endpoint Process Standards. https://www.fda.gov/files/drugs/published/Clinical-Trial-Imaging-Endpoint-Process-Standards-Guidance-for-Industry.pdf 2018.
2. Richesson RL, Hammond WE, Nahm M, Wixted D, Simon GE, Robinson JG, et al. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. J Am Med Inform Assoc. 2013;20(e2):e226–31. https://doi.org/10.1136/amiajnl-2013-001926.
3. Richesson RL, Smerek MM, Blake Cameron C. A Framework to Support the Sharing and Reuse of Computable Phenotype Definitions Across Health Care Delivery and Clinical Research Applications. EGEMS (Wash DC). 2016;4(3):1232. https://doi.org/10.13063/2327-9214.1232.
4. FDA. Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products (Guidance for Industry, Draft Guidance). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/real-world-data-assessing-electronic-health-records-and-medical-claims-data-support-regulatory 2021.
5. Banda JM, Seneviratne M, Hernandez-Boussard T, Shah NH. Advances in Electronic Phenotyping: From Rule-Based Definitions to Machine Learning Models. Annu Rev Biomed Data Sci. 2018;1:53–68. https://doi.org/10.1146/annurev-biodatasci-080917-013315.